Clinical trial

Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease

NCT02238197

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2001-02-01

PhaseN/A

Study timeline

Study start (unknown)2001-02-01Date precision: month

Registry last updated2014-09-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Atrovent® Inhalation SolutionDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02238197 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.